ArticleBioMed research international2015

miR-193b Modulates Resistance to Doxorubicin in Human Breast Cancer Cells by Downregulating MCL-1.

Jingpei Long et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.